Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers

Clinical trial NCT04910386 · NOT_YET_RECRUITING

Trial details

NCT number: NCT04910386
Sponsor: 3D Medicines (Sichuan) Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Neoplasms

Start date: 2027-06-01
Primary completion: 2029-06-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.